On August 9, 2017, WIB-San Francisco Bay Area hosted a panel discussion at Nektar Therapeutics in San Francisco, featuring four panelists and a moderator - all leaders in the field of Translational Research (TR).
After an introduction to Women In Bio by the Event Chair, Dorian Hirth, V.P. of Human Resources at Nektar welcomed the audience. The event was moderated by Maureen Cronin who recently retired from Celgene after a long, successful and dynamic career in TR. The panelists themselves were leaders in TR in varied therapeutic areas: Nancy Pryer from BioMarin is a leader, mentor, and currently involved with Rare Diseases. Oranee Daniels from Antiva, cares deeply for the causes of women and is presently working with anti-infectives. Victoria Sung and Ellen Filvaroff are brilliant scientists at Celgene and involved in various aspects of TR in Oncology. Each of these distinguished women came to TR in her own unique way.
Maureen asked the panel thought provoking questions. Discussion began by giving the audience an understanding of TR, which is not just bench-to-bedside but also returning back from bedside-to-bench. The area of TR has found solid roots in the era of big data. Understanding the mechanism of action of the drug and its effect on the patient (i.e., biomarker) are two big parts of TR. Being collaborative, adaptable, curious, interested in new technologies, and passionate were some of the character traits for success discussed by the panelists.
The audience was very engaged and there was a lively Q&A session after the discussion. Additionally attendees had the opportunity to chat with the panelists after the event.
The Women In Bio SF Chapter would like to thank Nektar Therapeutics for hosting the event in their wonderful facility. Food and wine at the beginning of the event was much enjoyed by the participants. Thank you to all participants, and a special thanks to the event Co-Chairs Vidula Dixit-Duarte and Audrey O’Neill for putting this event together!
Click here for more photos